Neurotransmitters are endogenous chemical messengers that play crucial roles in the transmission, enhancement and conversion of specific signals between neurons and other cells and are considered biomarkers of neurodegenerative diseases.[1] Neurodegenerative diseases cause progressive loss of cognitive and/or motor function and, as life expectancy rises, they imply major challenges for societies with rapidly aging populations.[2] As a result, monitoring neurotransmitters is becoming increasingly relevant in clinical environments. Acetylcholine (Ach) is a neurotransmitter that plays a key role in the communication between neurons in the spinal cord and nerve skeletal junctions in vertebrates. [3] Since an abnormal concentration of Ach has proven to be related to neurodegenerative diseases, novel strategies for highly sensitive and specific Ach (bio)sensing are in great demand.In this work we present the construction of Ach enzymatic biosensors with remarkable sensitivity by acetylcholinesterase immobilization on polyamine-modified single nanochannels via electrostatic self-assembly. [4] To fabricate bullet-shaped single nanochannels in polyethylene terephthalate (PET), 12 µm thick PET foils are irradiated with a single swift heavy ion. The resulting ion track consists of highly localized damaged material along the ion trajectory and is selectively dissolved in a highly basic aqueous solution under asymmetric conditions to obtain a bullet-shaped channel. The controlled PET hydrolysis exposes carboxylic groups at the channel surface (negative charge at pH < 4), which allows the immobilization of further functional groups to design and construct the biosensor.Here, we will discuss in detail the sensor design, the applied functionalization strategy, and the performance of the sensor. In short, changes in the surface charge of the nanochannel lead to measurable changes in the transmembrane current in a steady-state configuration. We will show experimental results that evidence that the designed sensor successfully transduces the presence of acetylcholine into measurable ionic signals with a 16 nM low limit of detection.[1] World Health Organization, Neurological Disorders: Public Health Challenges, World Health Organization Press, Geneva, Switzerland,2007.[2] L. Gan, M. R. Cookson, L. Petrucelli and A. R. La Spada,Nat. Neurosci., 2018, 21, 1300–1309.[3] M. Hasanzadeh, N. Shadjou and M. de la Guardia, TrAC, Trends Anal. Chem., 2017, 86, 107–121.[4] Yamili Toum Terrones, Gregorio Laucirica, Vanina M. Cayón, Gonzalo E. Fenoy, M. Lorena Cortez, María Eugenia Toimil-Molares, Christina Trautmann, Waldemar A. Mamisollé and Omar Azzaroni, Chem. Commun., 2022, 58, 10166